Global Blue Group
GB
$5.03
Share price
-0.59%
Change (1 day)
-7.20%
Change (1 year)
Categories
Global Blue Group (GB) - Cash on Hand
Cash on Hand as of December 2023 : $0.11 B
According to Global Blue Group's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Global Blue Group - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.26 B | 360.04% |
| 2022-03-31 | $57.01 M | -73.39% |
| 2021-03-31 | $0.21 B | -14.09% |
| 2020-03-31 | $0.24 B | 113.55% |
| 2019-03-31 | $0.11 B | 87.19% |
| 2018-03-31 | $62.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 20,347.90% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 7,321.25% | 🇮🇪 Ireland |
 Boston Scientific BSX | $0.86 B | 671.47% | 🇺🇸 USA |
 Edwards Lifesciences EW | $1.64 B | 1,366.68% | 🇺🇸 USA |
 Stryker Corporation SYK | $3.05 B | 2,622.88% | 🇺🇸 USA |